Antimicrobial stewardship and bamlanivimab: Opportunities for outpatient preauthorization?

Infect Control Hosp Epidemiol. 2021 Dec;42(12):1524-1526. doi: 10.1017/ice.2020.1343. Epub 2021 Nov 20.

Authors

Payal K Patel¹, Priya Nori², Michael P Stevens³

Affiliations

¹ Infectious Diseases Section, Ann Arbor Veterans' Affairs Medical Center, Ann Arbor, Michigan.
² Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
³ Healthcare Infection Prevention Department, Virginia Commonwealth University Health System, North Hospital, Richmond, Virginia.

PMID: 33213544
DOI: 10.1017/ice.2020.1343

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antibodies, Monoclonal, Humanized* / therapeutic use
Antibodies, Neutralizing / therapeutic use
Antimicrobial Stewardship*
Drug Utilization
Humans
Outpatients

Substances

Anti-Bacterial Agents
Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
bamlanivimab